πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12109224

USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in m

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12097291

Thermostable vaccine compositions and methods of preparing same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12084468

Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramid

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12054607

Tough, healable composites displaying stress relaxation at the resin-filler interface

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12042529

Optimization of enzyme replacement therapy for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12043601

N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatmen

The Regents of the University of Colorado Β· Granted Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12029732

Treatment of vascular and lymphatic disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12030911

Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12030958

Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides

The Regents of the University of Colorado Β· Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12018081

Photoconjugation reactions for modification of specific proteins on live cells

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12011390

Lacrimal drug delivery device

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11993638

GM-CSF mimetics and methods of making and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11981760

Therapeutic hydrogels and contact lens for corneal melting

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11974730

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado Β· Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11964985

Anti-cancer compounds targeting Ral GTPases and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11957737

Methods of treating microbial infection and inflammation

The Regents of the University of Colorado Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11932867

Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11933781

Fibrosis model and methods of use thereof

The Regents of the University of Colorado Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11911376

Methods for preventing and treating retinal damage

The Regents of the University of Colorado Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11903952

Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infe

The Regents of the University of Colorado Β· Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11904007

Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11851436

Fused bicyclic pyrimidine derivatives and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11833172

Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue r

The Regents of the University of Colorado Β· Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11806432

Compositions, methods and uses for thermally stable multi-targeted antigens

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted